病毒诱导的挥发性有机化合物可在肺部感染时于呼出气中检测到
该研究通过体外气道上皮细胞培养和体内人体采样,探究急性呼吸道病毒感染时挥发性有机化合物(VOC)产生的动态变化。研究发现包含癸烷及其他长链烷烃的VOC特征在鼻病毒感染时诱导产生,并在实验性鼻病毒挑战的健康受试者及COPD自然病毒性急性加重患者的呼出气中升高,且与抗病毒免疫反应、病毒载量和急性加重严重程度相关,但细菌感染未诱导该特征。
要点
- 呼出气中癸烷等长链烷烃构成的VOC特征可特异性指示病毒性呼吸道感染。
- 该VOC特征与抗病毒免疫反应、病毒载量及COPD急性加重严重程度相关。
- 细菌感染未诱导该VOC特征,提示其可用于区分病毒与细菌感染。
核心结论
- 呼出气VOC测量有望成为病毒感染的快速、无创生物标志物。
- 需进一步研究确定该特征能否指导COPD急性加重的靶向抗生素/抗病毒治疗。
研究设计与样本
- 采用体外与体内系列采样研究,体外使用感染气道上皮细胞培养,体内采集实验性鼻病毒A16挑战的健康受试者及自然发生急性加重的COPD受试者的呼出气样本。
- 使用高灵敏度气相色谱-质谱技术测量VOC产生。
主要发现
- 鉴定出包含癸烷及其他长链烷烃的新型VOC特征,在鼻病毒感染培养气道上皮细胞时诱导产生。
- 该VOC特征在实验性鼻病毒挑战的健康受试者及COPD自然病毒性急性加重患者呼出气中升高。
- 这些化合物与抗病毒免疫反应强度、病毒载量及急性加重严重程度相关,但细菌感染未诱导。
临床怎么用
- 呼出气VOC测量可能作为快速、无创的病毒性感染生物标志物用于临床。
- 该VOC特征有助于早期识别COPD急性加重的病毒触发因素,指导适当治疗。
局限性
- 需进一步研究确定该VOC特征测量能否指导COPD急性加重的靶向抗生素/抗病毒治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Chronic obstructive pulmonary disease (COPD) is a condition punctuated by acute exacerbations commonly triggered by viral and/or bacterial infection. Early identification of exacerbation triggers is important to guide appropriate therapy, but currently available tests are slow and imprecise. Volatile organic compounds (VOCs) can be detected in exhaled breath and have the potential to be rapid tissue-specific biomarkers of infection etiology. Objectives: To determine whether volatile organic compound measurement could distinguish viral from bacterial infection in COPD. Methods: We used serial sampling within in vitro and in vivo studies to elucidate the dynamic changes that occur in VOC production during acute respiratory viral infection. Highly sensitive gas chromatography-mass spectrometry techniques were used to measure VOC production from infected airway epithelial-cell cultures and in exhaled breath samples from healthy subjects experimentally challenged with rhinovirus (RV)-A16 and from subjects with COPD with naturally occurring exacerbations. Measurements and Main Results: We identified a novel VOC signature comprising decane and other long-chain alkane compounds that is induced during RV infection of cultured airway epithelial cells and is also increased in the exhaled breath from healthy subjects experimentally challenged with RV and from patients with COPD during naturally occurring viral exacerbations. These compounds correlated with the magnitude of antiviral immune responses, viral burden, and exacerbation severity but were not induced by bacterial infection, suggesting that they represent a specific virus-inducible signature. Conclusions: Our study highlights the potential for measurement of exhaled breath VOCs as rapid, noninvasive biomarkers of viral infection. Further studies are needed to determine whether measurement of these signatures could be used to guide more targeted therapy with antibiotic/antiviral agents for COPD exacerbations.
引用
- Kamal F, Kumar S, Edwards MR, et al. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection. Am J Respir Crit Care Med. 2021. PMID: 34319857. doi:10.1164/rccm.202103-0660OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。